Coral Laboratories Limited (BOM:524506)

India flag India · Delayed Price · Currency is INR
429.10
+10.05 (2.40%)
At close: Mar 5, 2026
Market Cap1.53B -42.0%
Revenue (ttm)875.55M -24.4%
Net Income139.84M -48.4%
EPS39.14 -48.4%
Shares Out3.57M
PE Ratio10.96
Forward PEn/a
Dividend1.50 (0.36%)
Ex-Dividend DateSep 19, 2025
Volume247
Average Volume2,460
Open423.00
Previous Close419.05
Day's Range419.30 - 434.95
52-Week Range415.00 - 796.95
Beta0.87
RSI39.92
Earnings DateFeb 13, 2026

About Coral Laboratories

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally. The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, ora... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 197
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524506
Full Company Profile

Financial Performance

In fiscal year 2025, Coral Laboratories's revenue was 1.15 billion, an increase of 37.47% compared to the previous year's 836.60 million. Earnings were 241.56 million, an increase of 52.99%.

Financial Statements